Upadhyay Suketu
SEC-identified person · CIK 1533149 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Incyte Corp INCY | EVP & Chief Financial Officer | filed 2026–2026 |
| Vertex Pharmaceuticals INC / MA VRTX | Director | filed 2022–2026 |
| Zimmer Holdings INC ZMH | Exec. VP, CFO | filed 2019–2026 |
| Endo International plc ENDP | EVP, Chief Financial Officer | filed 2014–2016 |
| Endo Pharmaceuticals Holdings INC ENDP | EVP, Chief Financial Officer | filed 2013–2014 |
| Becton Dickinson & CO BDX | Senior VP and Controller | filed 2011–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.